Suchergebnisse

Bioethics: Asian Perspectives: A Quest for Moral Diversity: - is the first volume on bioethics all contributors of which are exclusively non-western scholars; - unfolds a rich and colourful picture; - addresses thorny bioethical issues from comprehensive Asian perspectives and different from the western paradigm of bioethics; - covers many topics including the intellectual foundation of Asian bioethics, bioethics and Asian culture, life and death, euthanasia and end-of-life care in Asia; - shows in its discussions moral diversity in Asia; - sheds light on the debate about universal ethics, global ethics and moral diversity. The book is intended for senior undergraduate and graduate students interested in bioethics as well as for bioethicists, philosophers, physicians, scholars of Asian and culture studies, geneticists, sinologists, medical anthropologists, health administrators, health officials for relations with Asia, foundation officers for health programs in Asia, western journalists in Asia and officers of international organizations for Asia

This volume provides a unique perspective on the market reforms currently taking place in Chinese health care. The authors come to grips with the changes taking place in Chinese health care and its effect on the traditional doctor-patient relationship, but also its positive effects on the availability and quality of health care particularly in urban areas. In doing so the various authors wrestle with moral, political and social issues deeply ingrained in Chinese culture as well as the perceived practical and moral difficulties associated with the change to a market oriented economy especially

In view of the fact that for-profit enterprise exceeds public expenditures on genetic research and that benefits from the Human Genome Project may accrue only to rich people in rich nations, the HUGO Ethics Committee discussed the necessity of benefit-sharing. Discussions involved case examples ranging from single-gene to multifactorial disorders and included the difficulties of defining community, especially when multifactorial diseases are involved. The Committee discussed arguments for benefit-sharing, including common heritage, the genome as a common resource, and three types of justice: compensatory, procedural, and distributive. The Committee also discussed the importance of community participation in defining benefit, agreed that companies involved in health have special obligations beyond paying taxes, and recommended they devote 1–3% of net profits to healthcare infrastructure or humanitarian efforts.